Literature DB >> 12728413

Autologous blood transfusion after total knee arthroplasty: a randomized, prospective study comparing predonated and postoperative salvage blood.

Steven T Woolson1, William W Wall.   

Abstract

A randomized, prospective study of the use of allogeneic blood was performed in a consecutive series of patients who underwent primary total knee arthroplasty (TKA) and had autologous transfusion either from one unit of predonated autologous blood or from postoperative unwashed blood salvage. In this study, 83 patients (88 knees) were included, with 47 knees in the salvage group and 41 in the predonation group. There were no differences between groups in average age, height, and weight, or gender, diagnoses, or anesthesia type. No significant difference was seen between the groups in the prevalence of allogeneic blood transfusion (5% for the predonation group and 0% for salvage group). Postoperative blood salvage was as effective as predonated autologous blood in preventing the risk associated with allogeneic blood after TKA. Copyright 2003 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12728413     DOI: 10.1054/arth.2003.50058

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  20 in total

1.  Preoperative autologous blood donation in primary total knee arthroplasty: critical review of current indications.

Authors:  Dario Regis; Fabio Corallo; Massimo Franchini; Raffaella Rosa; Matteo Ricci; Pietro Bartolozzi
Journal:  Chir Organi Mov       Date:  2008-02-10

2.  Preoperative autologous blood donation in lower limb arthroplasty surgery: has the time come for its retirement?

Authors:  Manuel Muñoz; José A García-Erce
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

3.  Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

Authors:  Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

4.  Low vacuum re-infusion drains after total knee arthroplasty: is there a real benefit?

Authors:  Manuel Muñoz; Andrés Cobos; Arturo Campos
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

5.  Thromboembolic disease after knee arthroplasty is rare in Southern Iran.

Authors:  G Hossain Shahcheraghi; Mahzad Javid; Mohammad M Arasteh
Journal:  J Orthop       Date:  2014-01-31

6.  Reduced blood loss and operation time in lumbar posterolateral fusion using a bipolar sealer.

Authors:  Daisuke Fukui; Mamoru Kawakami; Shin-Ichi Nakao; Erabu Miyamoto; Shouko Morishita; Toshiko Matuoka; Hiroshi Yamada
Journal:  Eur Spine J       Date:  2016-06-08       Impact factor: 3.134

7.  Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty.

Authors:  Nael Hawi; Daniel Oliver Kendoff; Udo Hessling; Carl Haasper; Thorsten Gehrke; Mustafa Citak
Journal:  Int Orthop       Date:  2014-05-11       Impact factor: 3.075

8.  Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial.

Authors:  Johannes Cip; Mark Widemschek; Thomas Benesch; Roman Waibel; Arno Martin
Journal:  Clin Orthop Relat Res       Date:  2012-12-11       Impact factor: 4.176

9.  Allogeneic transfusion after predonation of blood for elective spine surgery.

Authors:  Kathleen F Brookfield; Mark D Brown; Steven M Henriques; Frank A Buttacavoli; Alison P Seitz
Journal:  Clin Orthop Relat Res       Date:  2008-05-26       Impact factor: 4.176

10.  The use of reinfusion drains after total knee arthroplasty in patients treated with low molecular weight heparin for thromboembolic prophylaxis.

Authors:  Alexander C Gordon; Pam Pulido; Steven N Copp; Kace A Ezzet; Richard H Walker; Clifford W Colwell
Journal:  HSS J       Date:  2005-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.